Belantamab mafodotin with standard care in transplant-ineligible newly diagnosed multiple myeloma: DREAMM-9 phase I study Meeting Abstract
| Authors: | Khalaf, Z.; Usmani, S. Z.; Mielnik, M.; Garg, M.; Sandhu, I.; Abdallah, A. O.; Koh, Y.; Oriol, A.; Quach, H.; Weisel, K. C.; Alonso, A.; Ocio, E. M.; Janowski, W.; Min, C. K.; Ramasamy, K.; Sánchez, R. G.; Rodríguez-Otero, P.; Brawley, C.; Egger, J. L.; Kaisermann, M. C.; Hus, M. |
| Abstract Title: | Belantamab mafodotin with standard care in transplant-ineligible newly diagnosed multiple myeloma: DREAMM-9 phase I study |
| Meeting Title: | 65th Annual Scientific Meeting of the British Society for Haematology (BSH) |
| Journal Title: | British Journal of Haematology |
| Volume: | 206 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2025 Apr 27-29 |
| Meeting Location: | Glasgow, Scotland |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2025-04-01 |
| Language: | English |
| ACCESSION: | WOS:001517858300119 |
| PROVIDER: | wos |
| DOI: | 10.1111/bjh.20117 |
| Notes: | Meeting Abstract: PO52 -- Source: Wos |
